-
1 Comment
Hebei Changshan Biochemical Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 2.3% below its 200 day moving average.
From a valuation standpoint, the stock is 72.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.7.
Hebei Changshan Biochemical Pharmaceutical Co., Ltd's total revenue rose by 19.4% to $628M since the same quarter in the previous year.
Its net income has increased by 4.2% to $74M since the same quarter in the previous year.
Finally, its free cash flow fell by 248.4% to $-32M since the same quarter in the previous year.
Based on the above factors, Hebei Changshan Biochemical Pharmaceutical Co., Ltd gets an overall score of 3/5.
| Industry | Biotechnology |
|---|---|
| ISIN | CNE1000016C2 |
| Exchange | SHE |
| CurrencyCode | CNY |
| Sector | Healthcare |
| Target Price | 9 |
|---|---|
| Beta | -0.06 |
| PE Ratio | None |
| Market Cap | 23B |
| Dividend Yield | None |
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally. It offers crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadri heparin calcium API, nandroparin calcium injection, and dalteparin sodium API and injection. The company was founded in 2000 and is based in Shijiazhuang, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300255.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
